John T. Treace Treace Medical Concepts, Inc. (TMCI) insider trading activity

John T. Treace is Chief Executive Officer of TREACE MEDICAL CONCEPTS, INC.. Currently has a direct ownership of 6.52 Million shares of TMCI, which is worth approximately $54.1 Million. The most recent transaction as insider was on Sep 16, 2024, when has been sold 50,000 shares (Common Stock) at a price of $5.31 per share, resulting in proceeds of $265,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6.52M

0.77% 3M change

16.03% 12M change

Total Value Held $54.1 Million

John T. Treace Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 16 2024	BUY Open market or private purchase	$265,500 $5.31 p/Share	50,000 Added 0.76%	6,523,095 Common Stock
Aug 14 2024	BUY Open market or private purchase	$510,000 $6.0 p/Share	85,000 Added 1.3%	6,473,095 Common Stock
Jun 11 2024	BUY Open market or private purchase	$264,600 $5.88 p/Share	45,000 Added 0.7%	6,388,095 Common Stock
May 17 2024	BUY Open market or private purchase	$556,000 $5.56 p/Share	100,000 Added 1.55%	6,343,095 Common Stock
May 14 2024	BUY Open market or private purchase	$768,000 $5.12 p/Share	150,000 Added 2.35%	6,243,095 Common Stock
May 13 2024	BUY Open market or private purchase	$683,999 $4.56 p/Share	150,000 Added 2.4%	6,093,095 Common Stock
May 10 2024	BUY Open market or private purchase	$687,000 $4.58 p/Share	150,000 Added 2.46%	5,943,095 Common Stock
Mar 10 2024	SELL Payment of exercise price or tax liability	-	5,021 Reduced 0.09%	5,793,095 Common Stock
Mar 08 2024	SELL Payment of exercise price or tax liability	-	2,064 Reduced 0.04%	5,798,116 Common Stock
Jan 10 2024	BUY Grant, award, or other acquisition	-	178,325 Added 2.98%	5,800,180 Common Stock
Mar 10 2023	BUY Grant, award, or other acquisition	-	82,475 Added 1.45%	5,621,855 Common Stock
Mar 09 2023	SELL Open market or private sale	$50,650 $24.41 p/Share	2,075 Reduced 0.04%	5,539,380 Common Stock
Nov 21 2022	BUY Open market or private purchase	$327,450 $21.83 p/Share	15,000 Added 0.27%	5,541,455 Common Stock
Nov 17 2022	BUY Open market or private purchase	$216,700 $21.67 p/Share	10,000 Added 0.18%	5,526,455 Common Stock
Sep 01 2022	BUY Open market or private purchase	$198,000 $19.8 p/Share	10,000 Added 0.18%	5,516,455 Common Stock
Aug 26 2022	BUY Open market or private purchase	$450,236 $20.95 p/Share	21,491 Added 0.39%	5,506,455 Common Stock
Aug 24 2022	BUY Open market or private purchase	$9,630 $18.92 p/Share	509 Added 0.01%	5,484,964 Common Stock
Aug 23 2022	BUY Open market or private purchase	$524,160 $18.72 p/Share	28,000 Added 0.51%	5,484,455 Common Stock
Mar 08 2022	BUY Grant, award, or other acquisition	-	33,875 Added 0.62%	5,456,455 Common Stock
Dec 29 2021	SELL Open market or private sale	$52,306 $17.01 p/Share	3,075 Reduced 0.06%	5,422,580 Common Stock
Dec 28 2021	SELL Open market or private sale	$335,722 $16.99 p/Share	19,760 Reduced 0.36%	5,425,655 Common Stock
Dec 27 2021	SELL Open market or private sale	$299,358 $17.44 p/Share	17,165 Reduced 0.31%	5,445,415 Common Stock
Dec 23 2021	SELL Open market or private sale	$386,603 $16.96 p/Share	22,795 Reduced 0.42%	5,462,580 Common Stock
Dec 22 2021	SELL Open market or private sale	$679,456 $16.29 p/Share	41,710 Reduced 0.75%	5,485,375 Common Stock
Dec 21 2021	SELL Open market or private sale	$609,988 $16.23 p/Share	37,584 Reduced 0.68%	5,527,085 Common Stock

JTT

John T. Treace

Chief Executive Officer

Jacksonville, FL

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TMCI shares.

Notify only if

Value

Insider Trading

Get notified when an Treace Medical Concepts, Inc. insider buys or sells TMCI shares.

Notify only if

Operation

Value

Type

News

Receive news related to TREACE MEDICAL CONCEPTS, INC.

Track Activities on TMCI

Account